Skip to main content

Find Clinical Trials

Home
Conditions
Histone Deacetylase Inhibitor

Clinical trial condition

Histone Deacetylase Inhibitor

Explore clinical trials studying Histone Deacetylase Inhibitor. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Histone Deacetylase Inhibitor trial results

Not Yet Recruiting

Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer

NCT07261592

Conditions: Bladder Cancer, Chemotherapy, Entinostat, +12 more
Locations: Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

NCT06890585

Conditions: BTK Inhibitors, Double Express Diffuse Large B-cell Lymphoma, Histone Deacetylase Inhibitor
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP

NCT01045538

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details